Home
Mail
Search
News
Finance
Sport
Lifestyle
Celebrity
Movies
Weather
Mobile
More
Yahoo
Mail
Cryptocurrencies
News
Property
Money
Markets
Industries
Watchlists
My Portfolio
My Screeners
Singapore markets closed
Straits Times Index
3,297.55
-26.98
(-0.81%)
Nikkei
38,102.44
-712.12
(-1.83%)
Hang Seng
17,936.12
-5.66
(-0.03%)
FTSE 100
8,142.61
-4.25
(-0.05%)
Bitcoin USD
65,687.20
-946.35
(-1.42%)
CMC Crypto 200
1,364.28
-23.88
(-1.72%)
Y-mAbs Therapeutics, Inc. (YMAB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
11.91
-0.14
(-1.16%)
At close: 04:00PM EDT
11.70
-0.21
(-1.76%)
Pre-market:
08:00AM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
84,499
84,819
65,267
34,897
20,750
-
Cost of revenue
11,480
11,416
7,567
2,514
2,203
-
Gross profit
73,019
73,403
57,700
32,383
18,547
-
Operating expenses
Research development
54,068
54,219
91,572
93,245
93,697
-
Selling general and administrative
44,030
44,856
60,939
54,571
44,785
-
Total operating expenses
98,098
99,075
152,511
147,816
138,482
-
Operating income or loss
-25,079
-25,672
-94,811
-115,433
-119,935
-
Interest expense
-
-
757
1,852
-
-
Total other income/expenses net
-
-
-
62,010
-
-
Income before tax
-20,945
-20,866
-95,568
-55,275
-119,337
-
Income tax expense
721
561
0
-
-
-
Income from continuing operations
-21,666
-21,427
-95,568
-55,275
-119,337
-
Net income
-21,666
-21,427
-95,568
-55,275
-119,337
-
Net income available to common shareholders
-21,666
-21,427
-95,568
-55,275
-119,337
-
Basic EPS
-0.45
-
-2.19
-1.28
-2.97
-2.30
Diluted EPS
-0.45
-
-2.19
-1.28
-2.97
-2.30
Basic average shares
43,656
-
43,704
43,182
40,119
35,183
Diluted average shares
43,656
-
43,704
43,182
40,119
35,183
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.